Content Quality: Well-structured News piece (Overview / What We Know / What We Don't Know), 471 words, within the 400-1200 word range for the News category. Neutral, factual tone throughout with no sensationalism, no editorializing, and no AI self-reference. The 'What We Don't Know' section appropriately flags the undisclosed post-money valuation and the ambiguity between Antares' 2028 deployment target and the EO 14299 September 30, 2028 deadline.
Source Verification: Read both source snapshots in full from disk (gunzip + HTML-to-text extraction) after verifying sha256 integrity against manifest.json (both matched exactly: source-0.html.gz = 4abcb46c4d3c8ef749a13591de7c9f2d51760b930fb60c48643b761c9adf8c66; source-1.html.gz = 313f6ca7c17775fdf818261dc48f4aed81a97a44462189a409b21f870d75dd34). Neither snapshot failed to save (both status_code 200, error: null), so no WebFetch fallback was needed. (1) sources/2026-07/antares-raises-470-million-series-c-to-build-nuclear-microreactors-for-the-us-military/source-0.html.gz (TechCrunch, Tim De Chant, 'Antares raises $470M to build nuclear reactors for the US military', July 27 2026) — confirmed: $470M raise ($370M equity + $100M debt), lead investors Paradigm and Caffeinated Capital with Industrious Ventures/Point72 Ventures/Shine Capital participating, 100kW-1MW TRISO-fueled SMR sized for up to 750 homes, Mark-0 reached criticality June 4 at Idaho National Laboratory, one of three Pentagon finalists in the Advanced Nuclear Power for Installations program with SMR testing on Air Force bases in Colorado and Montana, first electricity-producing reactor targeted 'next year' (2027, correctly inferred from the July 2026 publish date) with military deployments planned for 2028, prior $96M Series B 'also in December' bringing total funding to $604M, and Lazard's ~$214/MWh SMR cost estimate. (2) sources/2026-07/antares-raises-470-million-series-c-to-build-nuclear-microreactors-for-the-us-military/source-1.html.gz (Pulse 2.0, Amit Chowdhry, 'Antares Raises $470 Million Series C To Deploy Nuclear Microreactors For Critical Missions') — confirmed: both direct quotes are verbatim matches word-for-word — the Jordan Bramble (CEO and Co-founder, Antares) quote about 'the race to criticality' / 'race to commercialization' / $470M of equity and debt, and the Alana Palmedo (Managing Partner, Paradigm) quote about 'the first private advanced reactor criticality in decades.' Pulse2 also independently confirms the $370M/$100M equity/debt split, the investor list, the Mark-0 criticality at Idaho National Laboratory as 'the first privately developed non-light-water reactor to achieve criticality in the United States in more than four decades,' TRISO fuel, the Mark-1 2027 timeline, and verbatim confirms Executive Order 14299's September 30, 2028 deadline for the Department of War to operate a reactor at a domestic military installation. No hallucinated quotes or misattributed facts found in either snapshot. One overgeneralization found and logged as a finding above (the 'conventional power plants' vs. 'gas turbines' cost comparison). One minor sourcing note: the sentence attributing 'one of three Pentagon finalists' jointly to 'TechCrunch and Pulse 2.0' is only fully supported by TechCrunch verbatim ('one of three finalists'); Pulse2 confirms the Advanced Nuclear Power for Installations program and Air Force involvement but does not state the number 'three.' This is a minor joint-attribution looseness, not a fabrication (the underlying fact is true and confirmed by TechCrunch), so it does not rise to a separate corrections entry.
Factual Accuracy: All specific numbers, dates, names, and direct quotes trace to one or both cited sources with the two exceptions logged as findings (the cost-comparison overgeneralization, corrected below, and the pulse2.com allowlist gap, clarified below). The inferred year 'December 2025' for the prior Series B is not stated verbatim in either source (TechCrunch says only 'also in December') but is the only contextually sensible reading given the July 2026 publish date and is corroborated by the 'total funding to $604M' figure also confirmed in TechCrunch; not treated as a fabrication.
Overall Assessment: Substantively accurate, well-sourced, neutral News piece on a new (non-duplicate) financing story. Two recoverable issues -- an unlisted secondary source (content independently verified, not fabricated) and one overgeneralized cost comparison in a subordinate claim -- are each honestly summarized in the accompanying corrections record. Neither issue touches the headline, summary, or lead. APPROVE_WITH_CORRECTIONS.